Search

everythinglearnresearchcommunity

for

Search:↓

Combining narrow-band ultraviolet B light and stem cell transplantation helps repigmentation in vitiligo by maintaining calcium balance in mice.

15d‐PGJ2 cream protects against UVB-induced skin damage in mice.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

A specific gene mutation causes a rare hair loss condition in a Chinese patient.

Vitexin Compound 1 may help reduce skin aging caused by UVA light.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

5-aminolevulinic acid therapy reduces acne by decreasing fat production in skin cells.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

The research found ways to activate melanocyte stem cells for potential treatment of skin depigmentation conditions.

Acitretin effectively treats severe hypertrophic lichen planus.

Deep phenotyping helps distinguish between xeroderma pigmentosum and trichothiodystrophy, aiding in diagnosis and treatment.

Retinol acetate can reduce the harmful effects of the drug benoxaprofen on white blood cells.

Overexpressing thrombospondin-1 in mice skin prevents UVB-induced skin damage.

The hamster polyomavirus middle T antigen is linked to tumors in hamsters and associates with a specific tyrosine kinase.

Serotonin helps wounds heal faster.

A new mutation, Glu402Lys, in hair keratin is linked to variable symptoms of monilethrix.

A 532 nm laser at 15 J/cm2 speeds up tendon healing by increasing tendon stem cell growth and tendon-related gene activity.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Nanostructured lipid carriers are effective for treating hyperpigmentation in women aged 30-40.

A specific group of early-stage melanocytes is reduced in vitiligo-affected skin, which may explain treatment resistance.

Melatonin stops melanin production after tyrosinase action, with cyclic GMP mimicking this effect.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Both enzyme forms can sulfate minoxidil.